FORTRESS BIOTECH, INC.
(FBIO)Financial Statements · SEC EDGAR XBRL
Revenue
$63.3M
+9.7%
Net Income
$37.0M
+76.2%
EPS
$-0.07
+97.4%
Gross Margin
66.9%
Op. Income
-$70.2M
+36.4%
Source: SEC EDGAR XBRL
Breakdown
Revenues
Revenues
Total Revenues
Cost of Revenues
Gross Profit
Operating Expenses & Income
Selling General & Admin
Research & Development
Operating Income
Non-Operating Income/Expense
Other Non-Operating Income
Pre-Tax Income
Income Tax Expense
Net Income
EPS (Basic)
EPS (Diluted)
Shares Outstanding (Diluted)